Onkologie. 2012:6(2):74-78

Epidemiology of cervical, uterine and ovarian cancer in the world population

Edvard Geryk¹, Bohuslav Svoboda², Martina Kubecová³, Petr Kubíček⁴, Pavla Líbalová², Dalibor Pacík¹

¹ FN Brno-Bohunice

² Gynekologicko-porodnická klinika 3. LF UK a FNKV, Praha

³ Radioterapeutická a onkologická klinika 3. LF a FNKV, Praha

⁴ Geografický ústav Přírodovědecké fakulty MU, Brno

Of a total of 1.043 million worldwide new cases of cervical, uterine and ovarian cancer in 2008 based in Globocan 2008 (IARC), 31 % were

estimated in more developed and 69 % in less developed countries; of 489 thousand deaths from cancer, 27 % were in more developed

and 73 % in less developed countries. By 2030 an estimated worldwide increase is by 550 thousand, i.e. 53 % for new cases and 303 thousand,

i.e. 62 % for deaths. The expected increasing will be by 65 % up to 1.19 million new cases and 80 % up to 639 thousand deaths in less

developed countries, and by 19 % (up to 382 thousand new cases) and 29 % (up to 168 thousand deaths) in more developed countries.

Of the estimated five-year prevalence of 3.203 million cases worldwide there were 67 % in less, and 33 % in more developed countries

which included Europe with 677 thousand cases in 2008. On comparison of crude incidence rates of 40 European countries, Czech females

ranked alarming first in uterine, ninth in ovarian and eleventh in cervical cancer. The WHO appeal “Together It Is Possible” calls for a joint

effort to reduce the future incidence and disparities in cancer care.

Keywords: cancers of cervix uteri, corpus uteri and ovary, incidence, mortality, prevalence, expected numbers, selected world regions

Published: April 23, 2012  Show citation